Paradigm claims that iPPS is a 1B market for OA and that the drug is "statistically significant" and DMOAD. However, there doesn't appear to be any interest in partnering for OA...how could that be?
AGM Meeting
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.010(3.85%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.0¢ | $216.0K | 855.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 48298 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 119065 | 4 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
-0.010 ( 5.99 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 26.0¢ | 24.5¢ | 235895 | ||
| Last updated 15.56pm 21/05/2024 ? | |||||
| PAR (ASX) Chart |